Tech Company Financing Transactions
Imperagen Funding Round
PXN Ventures, IQ Capital Fund and Northern Gritstone joined a $6.7 million Seed funding round for Imperagen. The financing round closed on 5/21/2026.
Transaction Overview
Company Name
Announced On
5/21/2026
Transaction Type
Venture Equity
Amount
$6,700,000
Round
Seed
Investors
Proceeds Purpose
The new capital will be used to expand research and development, enhance wet lab capabilities, scale the company's AI team, and grow its commercial operations over the next 18 months.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Williams House Lloyd Street North, Manchester Science Park 11
Manchester, M15 6SE
UK
Manchester, M15 6SE
UK
Phone
Undisclosed
Website
Email Address
Overview
We believe nature already holds the potential to some of industry's biggest challenges, from greener manufacturing to improved diagnostics to the supply of advanced medicines. In order to realise this potential, enzymes must be optimized for their new purpose through engineering. Our mission is to transform enzyme engineering from trial-and-error into a predictable, scalable process that delivers the most improved enzymes to enable efficient and sustainable chemistry across industries.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 5/20/2026: Rightbrain AI venture capital transaction
Next: 5/21/2026: Draiven venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








